The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Site maintenance Monday, July 8th, 2024. Please note that access to some content and account information will be unavailable on this date.
ArticleNo Access

The Reversal of Anticholinergic Drug-Induced Delirium and Coma with Physostigmine

Published Online:https://doi.org/10.1176/ajp.127.8.1050

Although its use for this purpose is not well recognized, physostigmine provides an effective and safe treatment for delirium and coma caused by anticholinergic agents such as atropine, scopolamine, and hyoscyamine. The authors summarize the supporting evidence and outline a recommended procedure.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.